By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Pew PatriotsPew PatriotsPew Patriots
Notification Show More
Font ResizerAa
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Reading: Experimental cholesterol pill cuts heart attack risk with ‘convenient’ once-daily dose
Share
Font ResizerAa
Pew PatriotsPew Patriots
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Search
  • Home
  • News
  • Tactical
  • Guns and Gear
  • Prepping & Survival
  • Videos
Have an existing account? Sign In
Follow US
Experimental cholesterol pill cuts heart attack risk with ‘convenient’ once-daily dose
News

Experimental cholesterol pill cuts heart attack risk with ‘convenient’ once-daily dose

Jimmie Dempsey
Last updated: June 15, 2025 8:02 pm
Jimmie Dempsey Published June 15, 2025
Share
SHARE

NEWYou can now listen to Fox News articles!

A new daily pill could provide an easier, more convenient way to lower cholesterol and reduce heart attack and stroke risk.

The experimental medication, called Obicetrapib, underwent a Phase 3 clinical trial at Monash University in Australia.

The trial included more than 2,500 people averaging 65 years of age. All had either been diagnosed with heart disease or had genetically high cholesterol, according to a university press release. 

THIS CHEAP PANTRY STAPLE COULD BE KEY TO LOWERING CHOLESTEROL, NEW RESEARCH SUGGESTS

All participants were receiving “maximum tolerated doses” of cholesterol-lowering therapy.

One group received Obicetrapib and another group took a placebo, while still maintaining their existing cholesterol drugs. 

After 12 weeks, the participants taking the new drug showed a 32.6% reduction in LDL cholesterol and a 33.5% drop in lipoprotein(a) [Lp(a)], the release stated.

The findings were presented last month at the European Atherosclerosis Society Congress in the U.K. and were also published in The New England Journal of Medicine.

WOMEN’S HEART DISEASE RISK COULD BE PREDICTED UP TO 30 YEARS IN ADVANCE WITH ONE BLOOD TEST, STUDY FINDS

“We know that many people at high risk of heart attack or stroke don’t get their cholesterol levels low enough, even on the best available treatments,” said study lead Professor Stephen Nicholls, director of Monash University’s Victorian Heart Institute and Monash Health’s Victorian Heart Hospital, in the release.

“We know that many people at high risk of heart attack or stroke don’t get their cholesterol levels low enough, even on the best available treatments.”

“Obicetrapib offers a promising new option — not only did it lower LDL cholesterol by over 30%, but we also saw a reduction in Lp(a), which is much harder to treat and has been linked to increased heart disease risk.”

LDL cholesterol

Low-density lipoprotein (LDL), which is sometimes called “bad cholesterol,” is associated with negative health effects when present in high amounts.

LDL can build up in the blood vessels and increase heart attack and stroke risk, the researchers cautioned.

Lipoprotein(a), or Lp(a), is a protein that is known to greatly increase the chances of a heart attack when it’s present in high levels in the blood.

Unlike LDL, Lp(a) is an inherited risk factor that can’t be modified with healthy behaviors or medications.

Man holding chest

Obicetrapib was found to be “well-tolerated” by the participants, the researchers noted. 

“This could be a valuable tool in the fight against heart disease,” Nicholls added. “It’s convenient, it’s effective, and it may help close the gap for patients who’ve run out of options.”

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

The study — which was funded by NewAmsterdam Pharma, a developer of Obicetrapib that is based in the Netherlands — did have some limitations, the researchers noted.

man puts pill in mouth

For example, the participants were not chosen based on high Lp(a), which means the study did not determine how the drug impacted those with elevated levels of the protein.

Additionally, the study assessed changes in LDL levels, but did not measure actual heart attack or stroke outcomes.

For more Health articles, visit www.foxnews.com/health

More studies are needed to follow patients for longer time periods and to include more diverse cohorts, the researchers acknowledged.

Fox News Digital reached out to the researchers for additional comment.

Read the full article here

You Might Also Like

Olympics star Noah Lyles taunts NFL wide receiver Tyreek Hill after winning sprint

New York’s Suffolk County approves law punishing convicted animal abusers if they own pets

Jennifer Garner seen kissing boyfriend John Miller, as she spends time with Ben Affleck for Easter

World Series champ calls out AOC over response to Boulder attack

Pro-life leader praises bill requiring Ten Commandments in Texas schools: ‘A step in the right direction’

Share This Article
Facebook Twitter Email Print
Leave a Comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

We Recommend
Arkansas man charged with capital murder after killing parents in front of daughters at Devil’s Den State Park
News

Arkansas man charged with capital murder after killing parents in front of daughters at Devil’s Den State Park

Jimmie Dempsey Jimmie Dempsey July 31, 2025
Canada plans to recognize Palestinian state in September, PM Carney says
Graham family responds to global crackdown on Christians with $1.3M defense fund and urgent call to action
Passengers removed from plane, arrested for alleged vodka-induced drunk and disruptive behavior
Newlyweds’ honeymoon trip ends in fiery crash that kills husband and baby daughter
Film Star Shawn Ashmore Releases First Production Knife Design
Phillies make major trade deadline move for All-Star closer Jhoan Duran from Twins: reports
News

Phillies make major trade deadline move for All-Star closer Jhoan Duran from Twins: reports

Jimmie Dempsey Jimmie Dempsey July 30, 2025
Driscoll directs removal of former CISA director from West Point role
Tactical

Driscoll directs removal of former CISA director from West Point role

Jimmie Dempsey Jimmie Dempsey July 30, 2025
The Bubble Is Bursting: Delinquency Rates Have Doubled And Credit Card Defaults Are Soaring
Prepping & Survival

The Bubble Is Bursting: Delinquency Rates Have Doubled And Credit Card Defaults Are Soaring

Jimmie Dempsey Jimmie Dempsey July 30, 2025
Pew Patriots
  • News
  • Tactical
  • Prepping & Survival
  • Videos
  • Guns and Gear
2024 © Pew Patriots. All Rights Reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?